Clinical Trial Update: Surveillance of Synagis in Korean Pediatric Patients

View source ↗

Summary

A completed surveillance trial examining palivizumab (Synagis) use in Korean pediatric patients for respiratory syncytial virus infection, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Synagis (palivizumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Respiratory Syncytial Virus Infection | Status: COMPLETED | Results posted: 2015-07-10